FNY Investment Advisers LLC Makes New Investment in Doximity, Inc. (NASDAQ:DOCS)

FNY Investment Advisers LLC purchased a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,500 shares of the company's stock, valued at approximately $613,000.

A number of other large investors have also recently added to or reduced their stakes in the stock. GAMMA Investing LLC raised its stake in shares of Doximity by 20.6% in the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company's stock valued at $93,000 after purchasing an additional 296 shares in the last quarter. MetLife Investment Management LLC increased its holdings in Doximity by 0.6% in the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company's stock valued at $2,835,000 after buying an additional 363 shares during the last quarter. First Horizon Advisors Inc. raised its stake in Doximity by 22.5% during the third quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company's stock valued at $91,000 after buying an additional 384 shares in the last quarter. Farther Finance Advisors LLC lifted its holdings in Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock worth $34,000 after buying an additional 603 shares during the last quarter. Finally, KBC Group NV grew its position in shares of Doximity by 22.9% in the 3rd quarter. KBC Group NV now owns 3,296 shares of the company's stock worth $144,000 after acquiring an additional 614 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Canaccord Genuity Group reissued a "hold" rating and set a $60.00 price target (up from $40.00) on shares of Doximity in a research report on Wednesday, November 13th. Bank of America raised their price target on shares of Doximity from $54.00 to $57.00 and gave the stock a "neutral" rating in a research report on Monday, January 6th. Stephens assumed coverage on shares of Doximity in a research report on Friday, December 20th. They set an "equal weight" rating and a $55.00 price objective for the company. Raymond James restated an "outperform" rating and set a $65.00 price objective (up from $37.00) on shares of Doximity in a research note on Friday, November 8th. Finally, JPMorgan Chase & Co. lifted their price target on Doximity from $30.00 to $48.00 and gave the company a "neutral" rating in a report on Thursday, November 21st. Thirteen research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $53.12.

Doximity Stock Up 2.0 %

Shares of DOCS stock traded up $0.97 during trading hours on Tuesday, reaching $50.68. 1,239,841 shares of the stock traded hands, compared to its average volume of 1,586,568. The business has a fifty day moving average price of $53.40 and a 200 day moving average price of $42.09. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $61.75. The firm has a market capitalization of $9.46 billion, a PE ratio of 58.25, a PEG ratio of 4.13 and a beta of 1.38.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.